Gov. DeSantis hopes to add Eli Lilly, GlaxoSmithKline to monoclonal antibody arsenal
Gov. Ron DeSantis hopes more COVID-19 treatments, including Eli Lilly’s and GlaxoSmithKline’s antibody cocktails, will soon be readily available in Florida.
The Governor has spent more than a month in a hard push to promote Regeneron’s monoclonal antibody treatment. Despite previously downplaying Eli Lilly’s version for not being as effective against the delta variant, DeSantis was more optimistic about the option on Tuesday as he spoke in St. Cloud.
Florida is looking into how it could make those options readily available. Monoclonal antibody therapy, as produced by Regeneron, is a therapeutic available when a person at high risk for severe infection tests positive for COVID-19 or is expose...
